An association between ALDH1 expression and a particular molecular subtype of GB has been derived from the results of genome-wide profiling of transcriptomic or (epi)genomic landscapes using whole-tissue tumor specimens [19,20]. The gene discussed is ALDH1A1; the disease is neoplasm.